Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Sarah B May, Jennifer La, Emily Milner, Nimrah Riaz, Christopher I Amos, David A. Garcia, Marc Carrier, Neil Zakai, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, Nathanael Fillmore, Ang Li

Blood (2022) 140 (Supplement 1): 7968–7970.

https://doi.org/10.1182/blood-2022-162658

Published: 2022

Journal Articles

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Ang Li, Jennifer La, Sarah B May, Danielle Guffey, Wilson L Da Costa, Jr., Christopher I Amos, Emily Milner, Raka Bandyo, Carolina Granada, Nimrah Riaz, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil Zakai, Nathanael Fillmore

Blood (2022) 140 (Supplement 1): 5637–5639.

https://doi.org/10.1182/blood-2022-160017

Published: 2022

Journal Articles

Monocytosis at Diagnosis Is Associated with Decreased Overall Survival in Patients with Newly Diagnosed Multiple Myeloma

Camille V Edwards, MD, Cenk Yildirim, MS, Nathanael Fillmore, PhD, Nikhil C. Munshi, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-141584

Published: 2020

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Anusha Munjuluri, MSc, Nathanael Fillmore, PhD, Diana Cirstea, MD, Hassan Yameen, MD, Sarvari Venkata Yellapragada, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 4388.

https://doi.org/10.1182/blood-2019-131247

Published: 2019

Journal Articles

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Mehmet Kemal Samur, PhD, Gustavo A. Rivero, MD, Saiju Pyarajan, PhD, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 3191.

https://doi.org/10.1182/blood-2018-99-119490

Published: 2018

Journal Articles

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Sarvari Venkata Yellapragada, MD, Anna Frolov, M.S., M.A, Nathanael Fillmore, PhD, Pallavi Dev, Sumaira Shafi, MD, Ifeorah Chizoba, MPH, Do Nhan, MD, Do T Nhan, MD, Nikhil Munshi, MD

Blood (2018) 132 (Supplement 1): 1890.

https://doi.org/10.1182/blood-2018-99-117268

Published: 2018

NARROW

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Monocytosis at Diagnosis Is Associated with Decreased Overall Survival in Patients with Newly Diagnosed Multiple Myeloma

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Monocytosis at Diagnosis Is Associated with Decreased Overall Survival in Patients with Newly Diagnosed Multiple Myeloma

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

With Equal Access and Utilization of Resources,Younger African American Patients Have Superior Survival Compared to Caucasian Patients Diagnosed with Multiple Myeloma at the Veterans Affairs Hospitals

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only